Cipher Pharmaceuticals Inc. (CPHRF)

Cipher Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	305	278	267	97	70	33
Market Cap Growth	49.16%	4.23%	175.83%	38.09%	109.63%	83.01%
Enterprise Value	303.38	276.6	283.33	67.97	49.33	18.81
PE Ratio	11.17	10.45	21.70	5.23	2.75	4.83
Forward PE	-	18.41	15.93	11.11	8.77	3.95
PS Ratio	6.05	7.57	10.99	6.28	4.65	2.09
PB Ratio	2.42	3.03	3.58	1.65	1.50	1.18
P/TBV Ratio	-	-	3.53	1.75	1546.02	1.22
P/FCF Ratio	10.28	-	18.80	8.32	9.04	3.32
P/OCF Ratio	10.27	-	18.75	8.31	8.97	3.32
EV/Sales Ratio	6.02	7.53	11.66	4.41	3.28	1.18
EV/EBITDA Ratio	12.60	23.00	42.52	8.29	5.63	2.06
EV/EBIT Ratio	18.00	23.00	75.79	9.30	6.13	2.19
EV/FCF Ratio	10.22	-	19.95	5.84	6.36	1.87
Debt / Equity Ratio	0.04	0.04	0.39	0.00	0.01	0.01
Debt / EBITDA Ratio	0.33	0.33	4.43	0.03	0.04	0.04
Debt / FCF Ratio	-	-	2.08	0.02	0.04	0.04
Net Debt / Equity Ratio	-0.02	-0.02	0.22	-0.49	-0.44	-0.51
Net Debt / EBITDA Ratio	-0.12	-0.12	2.49	-3.51	-2.36	-1.60
Net Debt / FCF Ratio	-	-	1.17	-2.47	-2.67	-1.45
Asset Turnover	0.32	0.32	0.27	0.26	0.33	0.46
Inventory Turnover	1.43	1.43	2.11	1.59	2.10	2.90
Quick Ratio	0.75	0.75	1.59	8.55	3.80	2.21
Current Ratio	1.12	1.12	1.94	9.19	4.07	2.39
Return on Equity (ROE)	23.91%	23.80%	12.63%	28.19%	51.73%	21.69%
Return on Assets (ROA)	16.48%	16.53%	16.14%	20.18%	40.89%	17.27%
Return on Invested Capital (ROIC)	18.69%	18.74%	22.23%	39.12%	77.25%	30.77%
Return on Capital Employed (ROCE)	12.05%	12.05%	4.59%	13.82%	21.30%	32.04%
Earnings Yield	8.95%	9.57%	4.61%	19.14%	36.40%	20.71%
FCF Yield	9.73%	0.00%	5.32%	12.02%	11.06%	30.09%
Buyback Yield / Dilution	-	0.00%	0.01%	3.86%	1.93%	3.58%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.